Blancke Soares Alexandra, Meier Robert, Liebsch Gregor, Schwenk-Zieger Sabina, Kirmaier Martin E, Theurich Sebastian, Widmann Magdalena, Canis Martin, Gires Olivier, Haubner Frank
Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
PreSens Precision Sensing GmbH, Am Biopark 11, 93053, Regensburg, Germany.
Cancer Metab. 2021 May 4;9(1):21. doi: 10.1186/s40170-021-00257-6.
pO and pH are physiological parameters relevant for different processes in health and disease, including wound healing and cancer progression. Head and neck squamous cell carcinomas (HNSCC) and oesophageal squamous cell carcinomas (ESCC) have a high rate of local recurrence that is partly related to treatment-resistant residual tumour cells. Hence, novel diagnostic tools are required to visualise potential residual tumour cells and thereby improve treatment outcome for HNSCC and ESCC patients. We developed a device to spatiotemporally measure oxygen consumption rates (OCR) and extracellular acidification rates (ECAR) to distinguish HNSCC and ESCC cells from healthy cells in vitro, exploiting general metabolic differences between cancer cells and healthy cells.
OCR and ECAR were measured via a newly developed device named STOp-Q (SpatioTemporal O and pH Quantification) using the VisiSens technology based on ratiometric fluorescence imaging, facilitating spatiotemporal resolution. Results were confirmed using extracellular flux analyses (Seahorse technology).
STOp-Q is described and used to measure OCR and ECAR in HNSCC and ESCC cell lines and normal fibroblast and epithelial cells as components of the tumour microenvironment. OCR measurements showed differences amongst HNSCC and ESCC cell lines and between HNSCC/ESCC and normal cells, which on average had lower OCR than HNSCC/ESCC cells. Both OCR and ECAR measurements were independently verified using the Seahorse technology. Additionally, using STOp-Q, HNSCC/ESCC, and normal cells could be spatially resolved with a resolution in the low millimetre range.
We developed a method to spatiotemporally measure OCR and ECAR of cells, which has many potential in vitro applications and lays the foundation for the development of novel diagnostic tools for the detection of cancerous tissue in HNSCC and ESCC patients in vivo.
氧分压(pO)和pH值是与健康和疾病中的不同过程相关的生理参数,包括伤口愈合和癌症进展。头颈部鳞状细胞癌(HNSCC)和食管鳞状细胞癌(ESCC)的局部复发率很高,这部分与治疗抵抗性残留肿瘤细胞有关。因此,需要新的诊断工具来可视化潜在的残留肿瘤细胞,从而改善HNSCC和ESCC患者的治疗结果。我们开发了一种设备,用于时空测量氧消耗率(OCR)和细胞外酸化率(ECAR),以在体外区分HNSCC和ESCC细胞与健康细胞,利用癌细胞和健康细胞之间的一般代谢差异。
使用基于比率荧光成像的VisiSens技术通过一种名为STOp-Q(时空氧和pH值定量)的新开发设备测量OCR和ECAR,促进时空分辨率。使用细胞外通量分析(Seahorse技术)确认结果。
描述了STOp-Q并将其用于测量HNSCC和ESCC细胞系以及作为肿瘤微环境组成部分的正常成纤维细胞和上皮细胞中的OCR和ECAR。OCR测量显示HNSCC和ESCC细胞系之间以及HNSCC/ESCC与正常细胞之间存在差异,正常细胞的OCR平均低于HNSCC/ESCC细胞。使用Seahorse技术独立验证了OCR和ECAR测量。此外,使用STOp-Q,可以在低毫米范围内的分辨率下对HNSCC/ESCC和正常细胞进行空间分辨。
我们开发了一种时空测量细胞OCR和ECAR的方法,该方法具有许多潜在的体外应用,并为开发用于体内检测HNSCC和ESCC患者癌组织的新型诊断工具奠定了基础。